- Research Tracker
- Non-drug evidence map
- Intermittent hypoxia and hyperoxia
Controlled periods of breathing lower- or higher-oxygen air. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.
Trials by condition
Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.
What these trials measure
Primary outcomes, grouped by keyword rules: Heart rate, blood pressure and autonomic (12), Physical function and exercise capacity (8), Inflammation and other biomarkers (7), Weight and metabolic markers (6), Cognition (5), Feasibility, adherence and safety (3), Breathing and lung function (3), Fatigue and energy (2), Mood, anxiety and wellbeing (2), Pain (2), Symptom severity and disease activity (1), Sleep (1).
Names used for this class in the registry
shamed hypoxia (fio2: 20.9), acute intermittent hypoxia, normobaric hypoxia (fio2 15%), normobaric hypoxia (fio2 15%) under sildenafil, hyperoxia, normobaric hyperoxia, normobaric hypoxia (nh), mild intermittent hypoxia, normobaric hypoxia, altitude-like hypoxia (12% o2), intermittent hypoxia intervention, vaporous hyperoxia therapy
Download all 48 trials (CSV) All non-drug classes
Related in Oxygen, light, temperature and manual therapies: Hyperbaric oxygen therapy · Light and laser therapy (photobiomodulation) · Heat, cold and water therapies · Acupuncture and related techniques · Massage, osteopathy and manual therapy · Shock-wave and vibration therapy · Compression and counterpulsation
Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.